Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and as per Company's Code of Conduct for Regulating, Monitoring and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eiko Lifesciences has informed BSE that its trading window for insiders will be closed from Wednesday, 1st April 2026 until 48 hours after the upcoming board meeting. The reason for closure is the board's consideration of audited standalone and consolidated financial results for the quarter and full year ended 31st March 2026. All designated persons and their immediate relatives are restricted from trading in the company's shares during this period. The exact date of the board meeting will be communicated separately.
This is a routine regulatory compliance filing and not a material event. Investors should expect the FY2026 audited results announcement in the coming weeks, which is the typical trigger for trading window closures. No direct impact on shareholders or stock price is expected from this announcement itself.